Opening book details…
About this Medicine article
A randomized, open-label study to compare the efficacy and safety of AT1001 and enzyme replacement therapy (ERT) in patients with Fabry disease and AT1001-responsive GLA mutations, who were previously treated with ERT by Mathews Adera; Allison Gladden; Pol Boudes is a Medicine article available to read on EtoBox.
It is typically read by researchers, students, and practitioners in Medicine.
- Author
- Mathews Adera; Allison Gladden; Pol Boudes
- Publisher
- Elsevier Science; Elsevier ; Elsevier Inc.; Elsevier BV (ISSN 1096-7192)
- Published
- 2011
- Language
- EN
- Field
- Medicine (Health Sciences)
More by Mathews Adera; Allison Gladden; Pol Boudes
Browse all works by Mathews Adera; Allison Gladden; Pol Boudes